Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study
Open Access
- 1 January 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 6 (1), 75-8
- https://doi.org/10.1186/1477-7525-6-75
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasisBritish Journal of Dermatology, 2007
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialJournal of the American Academy of Dermatology, 2007
- Impact of adalimumab treatment on patient‐reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasisJournal of Dermatological Treatment, 2007
- Adalimumab treatment is associated with improvement in health‐related quality of life in psoriasis: Patient‐reported outcomes from a Phase II randomized controlled trialJournal of Dermatological Treatment, 2007
- Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension studyJournal of the American Academy of Dermatology, 2006
- Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trialBritish Journal of Dermatology, 2006
- Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trialBritish Journal of Dermatology, 2005
- Intramuscular Alefacept Improves Health-Related Quality of Life in Patients with Chronic Plaque PsoriasisDermatology, 2003
- The impact of psoriasis on quality of lifeBritish Journal of Dermatology, 2001
- SF-36 Summary ScoresMedical Care, 1998